David Halverson
Psychiatry · Atlanta, GANPI 1366886988
Payments from drug & device makers
Across 491 payments — averaging $19.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Supernus Pharmaceuticals, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$703
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$694
- Axsome Therapeutics, Inc.$553
- Johnson & Johnson$548
- plus $5K from 27 others
What the payments were for
- Food & beverage$9,44199%
- Education$771%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 77 | $1,136 |
| Supernus Pharmaceuticals, Inc. | 39 | $1,052 |
| Otsuka America Pharmaceutical, Inc. | 37 | $703 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $694 |
| Axsome Therapeutics, Inc. | 21 | $553 |
| Johnson & Johnson | 28 | $548 |
| Tris Pharma Inc | 28 | $527 |
| Corium, LLC | 25 | $486 |
| Neurocrine Biosciences, Inc. | 27 | $444 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $416 |
| Ironshore Pharmaceuticals Inc. | 18 | $401 |
| Lundbeck LLC | 20 | $348 |
| Bausch Health US, LLC | 16 | $311 |
| Neos Therapeutics, LP | 15 | $247 |
| Noven Therapeutics, LLC | 10 | $211 |
| Teva Pharmaceuticals USA, Inc. | 10 | $188 |
| Vanda Pharmaceuticals Inc. | 8 | $185 |
| Sunovion Pharmaceuticals Inc. | 8 | $160 |
| Adlon Therapeutics L.p. | 9 | $146 |
| Idorsia Pharmaceuticals US Inc | 7 | $130 |
| Shire North American Group Inc | 6 | $120 |
| Merck | 6 | $102 |
| Alfasigma USA, Inc. | 6 | $92 |
| Collegium Pharmaceutical, Inc. | 4 | $73 |
| Jazz Pharmaceuticals Inc. | 2 | $45 |
| Eisai Inc. | 3 | $42 |
| Avanir Pharmaceuticals, Inc. | 2 | $33 |
| Arbor Pharmaceuticals, Inc. | 2 | $25 |
| Alkermes, Inc. | 1 | $25 |
| Tempus AI, Inc | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Noven Pharmaceuticals, Inc. | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$170
How this compares
$9,518 in reported general payments places this provider in the 90th percentile of 900 psychiatry providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 13 | $1,367 |
| Bupropion XlBupropion Hcl | 17 | $284 |
| Fluoxetine Hcl | 13 | $171 |
| Escitalopram Oxalate | 13 | $170 |
| Lamotrigine | 14 | $140 |
| Alprazolam | 21 | $104 |
| Clonazepam | 16 | $94 |
| Zolpidem Tartrate | 12 | $78 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Atlanta
- Robert RiesenbergAtlanta$51.1M
- Saundra Maass-RobinsonAtlanta$11.1M
- David PurselleAtlanta$7.4M
- Bethany DavisAtlanta$4.4M
- Patricio Riva PosseAtlanta$884K
- Kerry ResslerAtlanta$365K
- Boadie DunlopAtlanta$345K
- Michael BurkeAtlanta$328K
- Bryon EvansAtlanta$211K
- Nurul HoqueAtlanta$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.